A Science-First Investment Firm
That Builds Its Own Intelligence
KTR Capital is a private investment firm founded in 2021 and headquartered in Austin, Texas. Our principal objective is to profit from advances in biotechnology and the life sciences. To pursue it, we have spent years building the intelligent systems we analyze and trade markets with — culminating in Helios, our proprietary engine for options-market intelligence.
Two Funds. One Research Platform.
KTR manages two investment vehicles, both supported by the same in-house research infrastructure and both open to accredited investors.
Biotechnology & Life Sciences
Long-term, high-conviction positions in U.S.-listed biotechnology equities together with selective private investments in oncology, biosensors, and advanced therapeutics. Scientific diligence is led from within the firm.
Options Strategies — Powered by Helios
Systematic and discretionary options strategies driven by Helios, our proprietary options-market intelligence engine. Real-time positioning and flow analytics inform entry, sizing, and risk. Currently raising capital.
Fund terms, structure, and performance are provided to qualified investors during diligence.
Headquartered in a Bioscience Hub
We chose Austin deliberately. Texas has become one of the fastest-growing life-sciences corridors in the United States, and Austin sits at its intersection with the country’s densest concentration of new technology talent.
Research Corridor
The University of Texas at Austin and Dell Medical School anchor a growing pipeline of translational research, spin-outs, and clinical innovation — with the Texas Medical Center in Houston, the largest medical complex in the world, three hours away.
Technology Density
Austin’s engineering and data-science talent base is what allows a firm of our size to build institutional-grade market intelligence in-house rather than buy it.
Capital & Structure
Texas offers a stable, business-forward jurisdiction for a partnership structure and direct access to a deep base of family offices, allocators, and operating companies.
Austin and Mexico City
Austin, Texas
500 W 2nd Street
Austin, TX 78701
United States
Research, Helios, and the operating core of the firm.
Mexico City
Anillo Perif. 3720, Jardines del Pedregal
01900 Ciudad de México, CDMX
Mexico
Investor coverage across Latin America and cross-border strategic opportunities.
Miami, Florida — coming soon.
Principal-Led
KTR is led directly by its founder, with significant personal capital invested alongside partners. A physician-founded firm, KTR brings scientific rigor to its biotechnology mandate and an engineering discipline to the systems it trades with.
Investor Access
KTR Capital is open to accredited investors. Qualification, documentation, and onboarding are handled through KTR Investments.
This page is informational and does not constitute an offer or solicitation to invest.